Our Approach

1

Evaluate

Survey the full scope of aging research to identify potential longevity technologies

  • MOLECULAR ALTERATIONS

    MOLECULAR ALTERATIONS

    Reverse the changes and damage to the genome and macromolecules

  • CELLULAR DYSFUNCTION

    CELLULAR DYSFUNCTION

    Restore homeostasis in metabolic activity and stress response

  • TISSUE DEGENERATION

    TISSUE DEGENERATION

    Regenerate tissues by altering the cellular and extracellular environment

2

Incubate

Validate the viability of a project and create the foundation for new ventures

  • EXPERTISE

    Establish collaborations with experts and key opinion leaders

  • INTELLECTUAL PROPERTY

    Identify, secure and protect IP and know-how

  • PROOF OF CONCEPT

    Design “killer experiment” to derisk project

  • R&D STRATEGY

    Define research and development plan and budget

3

Accelerate

Execute strategy for time and cost efficient development of novel therapeutics

  • TALENT & TEAM

    Leadership team with deep expertise in biotech, scientific and medical talent and advisors

  • LEAN OPERATIONS

    Lean and flexible drug development to maximize capital efficiency of start-ups

  • CLINICAL STRATEGY

    Clinical development for existing indications of high unmet medical need with clear regulatory paths

Our fields of interest

9 Features of aging | Apollo Ventures 9 Features of aging | Apollo Ventures
  • Genomic Instability

    Genomic Instability

  • Telomere Attrition

    Telomere Attrition

  • Stem cell exhaustion

    Stem cell exhaustion

  • Epigenetic Alterations

    Epigenetic Alterations

  • Loss of proteostasis

    Loss of proteostasis

  • Altered intercellular communication

    Altered intercellular communication

  • Mitochondrial dysfunction

    Mitochondrial dysfunction

  • Cellular senescence

    Cellular senescence

  • Deregulated nutrient sensing

    Deregulated nutrient sensing